M. Tselegkidi

Determining patterns of vascular function and structure in wild-type transthyretin cardiac amyloidosis. A comparative study.

M. Dimopoulos, I. Trougakos, E. Kastritis, 2022, International journal of cardiology.

Timing and impact of a deep response in the outcome of patients with systemic light chain (AL) amyloidosis

M. Dimopoulos, E. Kastritis, M. Gavriatopoulou, 2020, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Next generation flow cytometry for MRD detection in patients with AL amyloidosis

M. Dimopoulos, I. Trougakos, O. Tsitsilonis, 2020, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Consolidation with a short course of daratumumab in patients with AL amyloidosis or light chain deposition disease

M. Dimopoulos, O. Tsitsilonis, E. Kastritis, 2021, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Primary treatment of light-chain amyloidosis with bortezomib, lenalidomide, and dexamethasone.

M. Dimopoulos, O. Tsitsilonis, E. Kastritis, 2019, Blood advances.